Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Zumedha | Equity Research

Research · Analysis · Insights

Zumedha | Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Zumedha | Equity Research

Research · Analysis · Insights

Zumedha | Equity Research

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Industry
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
    • Multicap MFs
    • SIP Calculator
  • Master Class
  • Tools
    • MF Return Calculator
    • Loan Calculator
    • Tax Calculator
Close

Search

Home/Banking & Finance/IndusInd Bank Share Analysis April 2026
Banking & Finance

IndusInd Bank Share Analysis April 2026

By Zumedha Research Team on April 24, 2026 10 Min Read
IndusInd Bank — Zumedha Equity Research
Zumedha Equity Research
Research · Analysis · Insights
Current Market Price ₹780.00 as on 23 Apr 2026
Speculative Accumulate
IndusInd Bank Limited
Private Sector Banking · Hinduja Group · NSE: INDUSINDBK | BSE: 532187
NSEINDUSINDBK
BSE532187
ISININE095A01012
Face Value₹10
52W High₹1,695
52W Low₹600
Mkt Cap~₹60,700 Cr
IndexNifty 50 / Bank Nifty
Promoter~16.5%
01 Business Overview
⚠ Material Governance Event — Read Before Proceeding

IndusInd Bank is in the midst of a significant governance and accounting crisis. The bank disclosed derivatives mis-accounting in March 2025, resulting in a ~₹2,000 Cr one-time hit and ~₹2,329 Cr net loss in Q4 FY25. Former CEO Sumant Kathpalia and Deputy CEO Arun Khurana have resigned. SFIO has initiated a formal investigation. This report is a post-crisis recovery analysis and should be read accordingly.

IndusInd Bank Limited is a mid-sized private sector bank headquartered in Mumbai, promoted by the Hinduja Group and incorporated in 1994. It is a constituent of both the Nifty 50 and Bank Nifty indices, with approximately 42 million customers served through 3,120+ branches/banking outlets and ~3,063 ATMs across India. The bank operates across four reportable segments: Treasury, Corporate/Wholesale Banking, Retail Banking, and Other Banking Operations.

The bank’s business model has historically been skewed towards vehicle finance, microfinance (via subsidiary Bharat Financial Inclusion Ltd/BFIL), and mid-corporate lending — segments that are higher-yielding but carry elevated credit risk. This concentration, combined with insufficient internal controls over derivative accounting, led to the crisis that erupted in March 2025.

Under new MD & CEO Rajiv Anand (former Deputy MD, Axis Bank; appointed August 2025), the bank has embarked on a comprehensive restructuring under the “One IndusInd Bank” framework — targeting a unified asset-liability structure, tightened credit risk controls, leadership rebuild across risk, compliance, and technology, and a reorientation towards affordable housing, gold loans, and MSME lending.

Balance Sheet Size ₹5.26L Cr Dec 2025 (Q3 FY26)
Loan Book ~₹3.6L Cr Contracting in FY26
Deposits ₹3.94L Cr -3.8% YoY (Q3 FY26)
CASA Ratio 32.84% Down from 34.9% YoY
Capital Adequacy 16.94% CRAR (Basel III, Dec’25)
NIM (Q3 FY26) 3.52% vs. 3.93% (Q3 FY25)
Gross NPA ~3.5% Elevated; cleaning in FY26
Net NPA ~0.95% vs. 0.43% HDFC Bank
Q3 FY26 Net Profit ₹128 Cr vs. ₹1,402 Cr (Q3 FY25)
Employees ~44,970 As of Apr 2026
02 Historical Financials
Metric (₹ Crore)FY22FY23FY24FY25 (Restated)FY26E
Net Interest Income (NII)14,52817,42220,61619,031~16,500
Fee & Other Income7,1008,2009,3967,690~6,500
Total Operating Income~21,600~25,600~30,000~26,700~23,000
Operating Expenses10,20012,00014,14816,060~14,500
Pre-Provision Operating Profit11,40013,60015,86410,661~8,500
Provisions & Contingencies5,2004,8004,30011,200*~7,500
Net Profit / (Loss)4,6117,3898,950(2,329)~1,200
Net Interest Margin (NIM)4.10%4.20%4.29%~3.75%~3.55%
Return on Assets (RoA)1.18%1.65%1.86%(0.44%)~0.25%
Return on Equity (RoE)8.5%13.0%15.2%(4.2%)~2%

* FY25 provisions include ₹2,000 Cr derivatives one-time hit + ₹1,969 Cr microfinance classification reversal. FY26E are consensus-directional estimates pending Q4 FY26 results (board meeting: 24 Apr 2026). Historical NII for FY25 reflects restated figures.

The structural inflection: IndusInd’s NII peaked in FY24 at ₹20,616 Cr. The FY25 restatement and ongoing balance-sheet de-risking means FY26 NII will likely be the cyclical trough. Recovery cadence from FY27 is the central investment thesis.
03 DCF Valuation — Intrinsic Value Estimate

Given the earnings dislocation in FY25–FY26, a standard trailing-P/E or forward-P/E DCF is unreliable. We employ a Dividend Discount / Residual Income blend anchored to normalised FY28E earnings as the base year. We use a Price-to-Book approach calibrated against recovery ROE trajectory, cross-checked with a 10-year FCF-to-equity model.

DCF / RESIDUAL INCOME FRAMEWORK — KEY ASSUMPTIONS

14.5% Higher risk premium for governance overhang
10–12% vs. historical peak 15%; recovery assumption
5.0% Long-term nominal GDP proxy
~₹680 Post ECL impact absorption
Intrinsic Value Estimate
₹860 – ₹1,050
12-month fair value range (P/BV 1.2–1.5× FY27E book)
Based on FY28E normalised EPS of ~₹90, 10–12× P/E

The current CMP of ₹780 implies approximately 1.0–1.15× FY27E book value, which historically has been a strong support zone for IndusInd. This level provides a modest margin of safety for a recovery thesis, though governance overhang justifies a prolonged discount to book relative to ICICI Bank or HDFC Bank (both trading >2× book).

Emkay Global values the stock at 1.3× FY28E book / 11× FY28E EPS with a 12-month target of ₹1,100. Analyst consensus (27 reports) has an average target of ~₹856 with a wide dispersion of ₹539–₹1,266, reflecting deep uncertainty.

04 Buy Range — Entry Zones
Strong Buy Below ₹640
0.85× FY27E BV — deeply distressed; maximum margin of safety for long-term recovery
Accumulate ₹640 – ₹820
1.0–1.1× FY27E BV — current zone; attractive for investors willing to absorb governance risk
Fair Value Entry ₹820 – ₹950
1.1–1.3× FY27E BV — acceptable entry if execution evidence materialises

Current CMP (₹780) sits within the Accumulate zone. We recommend staggered accumulation with position sizing constrained to 3–5% of portfolio given binary governance risk from ongoing SFIO probe.

05 Buy Scenario Analysis
Bear Case ₹450 – ₹550

SFIO investigation leads to punitive action or capital call; credit costs remain elevated at 3%+; NIM fails to recover; fresh governance disclosures emerge; promoter stake pledge triggers selling pressure. Book value erosion to ₹580–₹620 range implies 0.75–0.9× P/BV.

Base Case (12-Month) ₹950 – ₹1,050

SFIO probe concludes without extreme penalties; Q4 FY26 results show stabilisation; credit costs normalise to ~1.6% by FY27; NIM recovers to 3.8–4.0%; new management executes “One IndusInd Bank” reset; loan growth returns to system levels in FY27. Target: 1.3× FY27E BV.

Bull Case ₹1,200 – ₹1,400

Rapid credit quality clean-up; ECL transition absorbed smoothly in FY27 opening networth; RoA rebounds to 1.3%+ by FY28; CASA recovers to 37%+; Rajiv Anand’s Axis Bank-style turnaround wins back institutional investor confidence; re-rating to 1.8× P/BV.

06 Sell Range — Exit Zones
Reduce ₹1,100 – ₹1,250
Begin trimming; 1.5–1.7× FY27E BV; re-rating may be priced in ahead of execution proof
Exit ₹1,250 – ₹1,450
Full exit unless recovery clearly exceeds base case; expensive vs. ICICI at similar BV multiples
Avoid (if entering) Above ₹1,450
Speculation territory; implies 2× FY27E BV without proven earnings recovery — unjustified risk/reward
07 Sell Scenario Analysis
Overvalued Signal ₹1,100 – ₹1,250

P/BV re-rates to 1.5–1.7× before earnings proof. Trim 30–50% of position. Monitor for execution slippage in MSME / affordable housing build-out.

Exit Trigger ₹1,250 – ₹1,500

Fresh adverse regulatory disclosure (RBI penalty, SEBI insider trading conviction, SFIO prosecution). Full exit warranted regardless of price. Also exit if NIM fails to recover by Q2 FY27.

Structural Break Below ₹580

Breach of FY27 book value. Signals balance sheet erosion beyond consensus estimates. Signals systemic credit book stress in vehicle finance or microfinance. Exit immediately and re-evaluate.

08 Future Growth & Earnings Outlook

FY26 Trough Year: IndusInd’s FY26 will be the earnings nadir. With Q3 FY26 net profit collapsing to ₹128 Cr (from ₹1,402 Cr a year ago), the full-year FY26 PAT is expected to be minimal (~₹1,200–₹1,500 Cr for the year vs. a loss in FY25). The bank is in active balance sheet clean-up mode — intentionally letting go of unprofitable loans and deposits, particularly in microfinance.

FY27 Recovery Pivot: Management has guided for credit costs moderating to ~1.6% in FY27 (from ~2.6% in FY26). Loan growth is projected to return to double-digit expansion. The new management is targeting an RoA of ~1% by end-FY27 — still below the sector leader ICICI Bank’s ~2.3% RoA but a material recovery from near-zero levels.

ECL Transition Risk: The bank expects to transition to Expected Credit Loss (ECL) provisioning standards from FY27. Management has indicated a transitional ECL impact of 1.5–1.7% of loans (pre-tax), which will likely be absorbed via opening net worth rather than hitting the P&L — a critical technical distinction for earnings visibility.

MetricFY26EFY27EFY28E
NII (₹ Cr)~16,500~19,500~23,000
NIM~3.55%~3.80%~4.00%
Credit Cost~2.6%~1.6%~1.2%
PAT (₹ Cr)~1,200~4,500~7,500
EPS (₹)~16~58~96
RoA~0.25%~0.90%~1.35%
RoE~2%~8%~12%

FY26E–FY28E: Zumedha estimates based on analyst consensus, management guidance, and Emkay/IDBI Capital projections. Subject to material revision pending Q4 FY26 results (24 Apr 2026).

Growth Segments: Rajiv Anand has articulated a pivot toward affordable housing, gold loans, and MSME lending as the new growth anchors — all higher-quality segments with lower charge-off volatility versus the legacy microfinance and commercial vehicle concentration. The bank is also targeting a doubling of monthly account openings to strengthen the liability franchise and arrest CASA ratio decline (currently at 32.84%, down from 34.9%).

09 Risks & Catalysts
Catalysts (Bull Factors)
  • + SFIO investigation concludes without extreme penalties or capital call — removes single largest overhang
  • + Q4 FY26 results (24 Apr 2026) show PPOP stabilisation or positive surprise — first hard evidence of recovery
  • + Rajiv Anand’s leadership credibility (Axis Bank turnaround track record) rebuilds institutional confidence; FII re-allocation could be catalytic
  • + RBI rate cuts lower cost of funds; CASA recovery reduces deposit cost drag and expands NIMs
  • + ECL transition absorbed via net worth (not P&L) — eliminates a feared one-time earnings hit in FY27
  • + Promoter (Hinduja Group) inter-se stake transfer and capital availability signals provide a credibility floor
  • + Credit growth rebound in vehicle finance and commercial segment as economic activity normalises
  • + CARE A1+ rating reaffirmation (Apr 2026) preserves access to short-term funding markets at competitive rates
Risks (Bear Factors)
  • – SFIO prosecution of former senior executives escalates to bank-level action; regulatory penalties materially impair capital
  • – SEBI insider trading conviction of ex-CEO Kathpalia & ex-Deputy CEO Khurana creates reputational overhang that deters institutional buyers
  • – Microfinance asset quality further deteriorates; sector-wide stress from over-leveraged borrowers in rural India
  • – CASA ratio continues declining — raising cost of funds and compressing NIM recovery timeline
  • – Promoter pledge (6.45% stake pledged for debt refinancing, Apr 2026) creates stock-level selling pressure on any sharp decline
  • – ECL transitional impact turns out larger than guided 1.5–1.7%; hits opening net worth significantly, diluting book value
  • – New CEO fails to retain/attract top talent; leadership bench remains thin across risk and compliance functions
  • – Broader private banking sector re-pricing risk — competitive pressure from well-capitalised ICICI Bank and HDFC Bank accelerates market share loss
10 Peer Comparison
BankCMP (₹)Mkt Cap (₹Cr)P/BV (FY26E)P/E (FY27E)NIM (%)Gross NPA (%)RoA (%)RoE (%)Rating
IndusInd Bank ★78060,700~1.05×~13×3.52%~3.5%~0.25%~2%Spec. Accumulate
ICICI Bank~1,430~10.1L Cr~2.8×~16×4.35%1.96%2.30%18.5%Buy
HDFC Bank~1,920~14.5L Cr~2.4×~17×3.50%1.33%1.95%16.2%Accumulate
Kotak Mahindra Bank~2,050~4.1L Cr~3.2×~19×5.00%1.50%2.40%14.0%Accumulate
Axis Bank~1,180~3.6L Cr~1.9×~13×4.00%1.53%1.85%16.5%Accumulate
YES Bank~21~66,000~1.1×~22×2.40%1.60%0.55%5.0%Accumulate LT

IndusInd Bank currently trades at the lowest P/BV among large private banks, reflecting the governance discount. However, on an FY27E recovery basis, the upside to 1.3–1.5× P/BV remains intact if execution holds. The key comparative metric to watch is the NIM recovery — at 3.52%, IndusInd is already below HDFC Bank (3.50%) with far more structural risk; a failure to expand NIM to 3.80%+ by FY27 would invalidate the base case.

Recovery at a Discount — But Governance Risk Is Real

IndusInd Bank is one of the most complex investment propositions in the Indian banking sector today. The stock has lost over 50% from its 52-week high of ₹1,695 — a collapse driven by a perfect storm of derivatives mis-accounting (dating back to FY16), a leadership vacuum, SFIO prosecution, and microfinance asset quality stress.

Yet at ₹780, the market is pricing the bank at ~1.05× estimated FY27 book value — a level that has historically marked durable bottoms for mid-tier private banks in India. The appointment of Rajiv Anand — a credible, experienced banker — alongside tangible evidence of balance-sheet triage (letting go of unprofitable loans, tightening microfinance underwriting) provides the beginnings of a recovery narrative.

The central risk is not the economy. It is governance. The SFIO probe, SEBI insider trading actions, and the promoter pledge structure are binary event risks that traditional valuation models cannot adequately price. Investors must size positions accordingly and maintain strict stop-loss discipline around the ₹580 book-value floor.

For long-horizon investors with a 24–36 month view and tolerance for high governance uncertainty, IndusInd Bank offers asymmetric upside: a 35–45% return to base case (₹950–₹1,050) versus a manageable downside to ₹580–₹640 in the bear case, assuming no punitive capital action. We assign a Speculative Accumulate rating — staggered entry in the ₹640–₹820 zone, position size capped at 3–5% of portfolio.

Q4 FY26 results (board meeting 24 Apr 2026) are the next critical data point. A meaningful PPOP stabilisation or management upgrade on credit cost trajectory would be a material positive catalyst.

Zumedha Rating SPECULATIVE
ACCUMULATE
12-Month Base Case Target ₹950 – ₹1,050
Bear Case / Stop-Loss ₹580 Bull Case (24–36 Month) ₹1,300 – ₹1,500
Recommended horizon: 24–36 months
Max position: 3–5% of portfolio
Next trigger: Q4 FY26 results, 24 Apr 2026
Disclaimer: This research report is prepared by Zumedha Equity Research for informational and educational purposes only. It does not constitute investment advice, a solicitation, or an offer to buy or sell any securities. The information contained herein is based on publicly available sources believed to be reliable; however, Zumedha Equity Research makes no representation as to its accuracy or completeness. Equity investments are subject to market risks. Past performance is not indicative of future results. Readers should conduct their own due diligence and consult a SEBI-registered investment advisor before making any investment decision. Zumedha Equity Research and its personnel may or may not hold positions in the securities mentioned. This report is not intended for distribution to or use by any person in any jurisdiction where such distribution would be contrary to local laws or regulations. All financial data referenced pertains to publicly disclosed filings as of the date of publication (23 April 2026). IndusInd Bank’s Q4 FY26 results are pending as of the publication date of this report.

Author

Zumedha Research Team

Follow Me
Other Articles
Previous

Vishal Mega Mart Share Price Analysis April 2026

Next

Delhivery Limited Share Price Analysis April 2026

Legal Disclaimer Investment Research & Information

Not Investment Advice. All content published on this website — including stock analyses, mutual fund reviews, DCF models, valuation estimates, buying zones, and commentary — is created for our own educational, internal research and informational purposes only. Nothing on this website constitutes financial, investment, legal, or tax advice, nor a solicitation or recommendation to buy, sell, or hold any security or financial instrument.

No Guarantees. It is advised clearly and categorically not o follow these analysis and information blindly for your equity investement purpose as Equity investments and mutual funds are subject to market risks. Past performance is not indicative of future results. All DCF models, fair value estimates, and scenario analyses are based on publicly available data and the author's independent assumptions and may prove materially incorrect. The author/s or owners of this website/portal do not are not liable in whatsoever manner for any positive or negative outcome from your own investment endeavorsYou may lose part or all of your invested capital.

Do Your Own Research. Readers are strongly advised to consult a SEBI-registered investment advisor and conduct their own due diligence before making any investment decision. The author may or may not hold positions in securities discussed on this website.

No Obligations. We, the author/ the publisher/ anybody associated with Zumedha.com does not guarantee the accuracy, adequacy or completeness of any information/data and is not responsible for any errors or omissions or for the results obtained from the use of such information/data. Zumedha.com or anyone involved with zumedha.com will not accept any liability for loss or damage as a result of reliance on the Estimates data. It does not subscribe or endorse any of the services and/or content offered by such third party.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
This website is not registered as an Investment Adviser under SEBI (Investment Advisers) Regulations, 2013. All views are personal and for informational purposes only.
© 2026 · All Rights Reserved · For Educational Use Only. RESEARCH · ANALYSIS · INSIGHTS